These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 602619)

  • 21. Effects of ornithine alphaketoglutarate on blood insulin, glucagon and aminoacids in alcoholic cirrhosis.
    Gay G; Villaume C; Beaufrand MJ; Felber JP; Debry G
    Biomedicine; 1979 Jul; 30(3):173-7. PubMed ID: 486688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [On therapy of hepatic coma with metabolites of the urea cycle, glutamate and alpha-ketoglutarate].
    Meuret G; Beck K; Keul J; Gruenagel HH
    Dtsch Med Wochenschr; 1968 Jun; 93(24):1194-7. PubMed ID: 5651556
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of normalization of plasma amino acids on hepatic encephalopathy in man.
    Fischer JE; Rosen HM; Ebeid AM; James JH; Keane JM; Soeters PB
    Surgery; 1976 Jul; 80(1):77-91. PubMed ID: 818729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Correction by L-dopa of neurologic manifestations of a chronic portocaval encephalopathy].
    Girard PF; Trillet M; Kopp N
    Rev Neurol (Paris); 1972 Nov; 127(5):560-3. PubMed ID: 4668744
    [No Abstract]   [Full Text] [Related]  

  • 25. [Essential phospholipids in the treatment of hepatic encephalopathy].
    Brůha R; Marecek Z
    Vnitr Lek; 2000 Apr; 46(4):199-204. PubMed ID: 11227171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of mortality in hepatic encephalopathy in acute and chronic liver disease: a preliminary observation.
    Udayakumar N; Subramaniam K; Umashankar L; Verghese J; Jayanthi V
    J Clin Gastroenterol; 2007; 41(10):922-6. PubMed ID: 18090162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute cerebral edema as part of the syndrome of hepatic encephalopathy in an individual with chronic liver disease: a case report.
    Jabbour N; Karavias D; Van Thiel DH
    J Okla State Med Assoc; 1994 Nov; 87(11):501-3. PubMed ID: 7815183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Normal protein diet and L-ornithine-L-aspartate for hepatic encephalopathy.
    Ndraha S; Simadibrata M
    Acta Med Indones; 2010 Jul; 42(3):158-61. PubMed ID: 20724770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of hepatic encephalopathy with branched-chain amino acids (BCAA) by oral route: II. Chronic hepatic encephalopathy].
    Caballería Rovira E; Arago López JV; Masso Ubeda RM; Vidal Clemente JL; Sanchís Closa A
    Rev Esp Enferm Apar Dig; 1987 Sep; 72(3):201-5. PubMed ID: 3685578
    [No Abstract]   [Full Text] [Related]  

  • 30. Simvastatin for rats with thioacetamide-induced liver failure and encephalopathy.
    Huang HC; Wang SS; Lee FY; Chan CY; Chang FY; Lin HC; Chu CJ; Chen YC; Lee SD
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e236-42. PubMed ID: 17573832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study.
    Stauch S; Kircheis G; Adler G; Beckh K; Ditschuneit H; Görtelmeyer R; Hendricks R; Heuser A; Karoff C; Malfertheiner P; Mayer D; Rösch W; Steffens J
    J Hepatol; 1998 May; 28(5):856-64. PubMed ID: 9625322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical trial of alpha ornithine ketoglutarate].
    Linquette M; Fossati P; Hubschman B
    Lille Med; 1969 Apr; 14():Suppl 3:512-5. PubMed ID: 5376446
    [No Abstract]   [Full Text] [Related]  

  • 33. [Complex therapy of chronic hepatic encephalopathy supplemented with probiotic: comparison of two studies].
    Boca M; Vyskocil M; Mikulecký M; Ebringer L; Kolibás E; Kratochvíl'ová H; Buzgová D
    Cas Lek Cesk; 2004; 143(5):324-8. PubMed ID: 15305769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration.
    Clemmesen JO; Larsen FS; Kondrup J; Hansen BA; Ott P
    Hepatology; 1999 Mar; 29(3):648-53. PubMed ID: 10051463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective effect of L-carnitine in ammonia-precipitated encephalopathy in the portacaval shunted rat.
    Therrien G; Rose C; Butterworth J; Butterworth RF
    Hepatology; 1997 Mar; 25(3):551-6. PubMed ID: 9049197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of treatment with the Molecular Adsorbents Recirculating System on arterial amino acid levels and cerebral amino acid metabolism in patients with hepatic encephalopathy.
    Schmidt LE; Tofteng F; Strauss GI; Larsen FS
    Scand J Gastroenterol; 2004 Oct; 39(10):974-80. PubMed ID: 15513337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebral blood flow velocity increases during a single treatment with the molecular adsorbents recirculating system in patients with acute on chronic liver failure.
    Schmidt LE; Svendsen LB; Sørensen VR; Hansen BA; Larsen FS
    Liver Transpl; 2001 Aug; 7(8):709-12. PubMed ID: 11510016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Parenteral feeding of patients with liver cirrhosis with hepatic encephalopathy].
    Ferenci P; Wewalka F
    Infusionsther Klin Ernahr; 1980 Apr; 7(2):72-8. PubMed ID: 6776052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of hepatic encephalopathy with oral branched-chain amino acids: I. Acute hepatic encephalopathy].
    Caballería Rovira E; Arago López JV; Masso Ubeda RM; Vidal Clemente JL; Sanchís Closa A
    Rev Esp Enferm Apar Dig; 1987 Aug; 72(2):116-22. PubMed ID: 3659529
    [No Abstract]   [Full Text] [Related]  

  • 40. Plasma gamma aminobutyric acid concentrations provide evidence of different mechanisms in the pathogenesis of hepatic encephalopathy in acute and chronic liver disease.
    Levy LJ; Losowsky MS
    Hepatogastroenterology; 1989 Dec; 36(6):494-8. PubMed ID: 2613171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.